Kenneth Locke
Chief Technical OfficerMr. Kenneth Locke, also known as Ken, is Chief Technical Officer of ProKidney Corp. from June 2026. Mr. Locke served as Senior Vice President of Technical Operations at Carisma Therapeutics Inc. since 2024 until 2025. Mr. Locke is Member of Strategic Advisory Board of iVexSol Inc. since May 2023. Prior to joining Carisma, he served as Global Head of Cell Therapy External Manufacturing and Strategic Sourcing at Bristol Myers Squibb (formerly Celgene/Juno Therapeutics) where he was responsible for all external manufacturing operations for plasmid, viral vector and cell processing. Prior to BMS, Mr. Locke was Executive Director at Novartis supporting global materials and services sourcing for all Technical R&D as well as Cell and Gene Therapies. Mr. Locke has years of pharmaceutical and biotechnology experience, including discovery, laboratory automation, sourcing/contracting strategy, supply chain and manufacturing. Mr. Locke has M.S. in Molecular Biology from Lehigh University. Mr. Locke has B.S. in Biology from Millersville University Of Pennsylvania.
Positions
- Company NameProKidney Corp.Stock CodePROKPositionChief Technical OfficerColleagues
- BCBruce CulletonCEO & Director
- PLPablo LegorretaChairman of the Board
- JCJames CoulstonChief Financial Officer
- TCTodd C. GirolamoChief Legal Officer & Secretary
- RWRichard WilliamsChief Information Officer
- WFWilliam F. DoyleLead Independent Director
- AMAlan M. LotvinIndependent Director
- JAJennifer A. FoxIndependent Director
